Henderson, Nevada – November 24, 2020 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced changes to its senior management team and its Board of Directors. Douglas Beplate, co-founder of the company and currently Chief Executive […]
Press Releases
Journal of Wound Care to Publish Peer Reviewed Article on HemoStyp® Human Trial
Henderson, Nevada – October 26, 2020 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced that the London based Journal of Wound Care has informed the Company that UHP’s submitted article, Efficacy and Safety of HemoStyp as an Adjunct for […]
United Health Products Submits HemoStyp® Completed PMA Response to FDA
HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTCPK: UEEC, “UHP”) today announced that it has submitted documents requested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal surgeries. The company expects the FDA to grant approval to its PMA (Class III) application or request additional information within 30 days. […]
United Health Products Announces HemoStyp® Human Trial Results to be Available on ClinicalTrials.gov
HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTCPK: UEEC, “UHP”) today announced that it has uploaded the full results of its Human Trial study, Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting, to the ClinicalTrials.gov website; these results are expected to be made available to the public within 7-14 days. […]
United Health Products Files HemoStyp® Hydrocolloid Patents
HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), today announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid (gel) format of its HemoStyp oxidized regenerated cellulose product, and has also filed a separate application under the Patent Cooperation Treaty with the […]
United Health Products Announces FDA Update Post-Dialysis Patch Product Developed
HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC), (“UHP” or the “company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 Oct 15,2013) for the healthcare and wound care sectors, today announced that is has recently received correspondence from the FDA regarding its current PMA class […]